Fourth, the effects of drugs used for nephrotic syndrome, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, sodium-glucose cotransporter-2 inhibitors, and steroids, were not tested in the current mouse model. Here, SLC5A2 is linked to nephrotic syndrome.